These four high-quality stocks could be a good addition to a conservative investor's portfolio.
Premature disappointment over the prospect of Vanda's sole drug has left investors with a compelling opportunity says Morningstar Opportunistic Investor's Stephen Ellis.
Adding more asset classes, not more securities, is the best way to diversify.
We think 2010's stock rally has been justified by the fundamentals.
We look back at the best, and worst, picks from 2009's Ideas Week.
The market is undervaluing PepsiCo's bright emerging market prospects says Morningstar's Phil Gorham.
Probably in the first quarter, we're going to see the first major round of dividend increases from the country's big banks that have returned to profitability, says Morningstar's Josh Peters.
The recent sell off in Muni bonds is being precipitated more by a supply/demand imbalance than a loss of confidence in credit quality says 16th Amendment Advisors' Jed McCarthy.
These stocks are far from bargains.
With telecom bonds in the U.S. and Europe looking richly valued, investors should focus on high-yielding telecom stocks says Morningstar's Mike Hodel.
We look at some potential reasons why foreign stocks aren't as great diversifiers today as they were in the past.
Though the Fed is injecting a huge amount of money into the financial system, there is no guarantee those dollars are going to get back out into the real economy, says Morningstar's Josh Peters.
Morningstar's Josh Peters on recent market volatility, dividend-stock valuations, and some dividend-payers that have come through in tough times.
Morningstar's Dave Whiston thinks the new and improved GM is going to be a formidable cash flow generator when auto demand rebounds.
Morningstar's Timothy Strauts outlines two intriguing ways to access emerging markets.
A difference of opinion between the rating agencies and Morningstar's credit rating on Compass Minerals spells opportunity.
Morningstar's Paul Swinand on which European stocks investors should keep on their radar screens and which they should ignore.
Morningstar's Scott Burns takes a critical eye to recent reports on the dangers of ETFs.
With few bargains remaining in dividend stocks, investors should be focused on buying the highest quality firms says Morningstar's Josh Peters.
Though its current deflation-fighting actions are valuable, charting a successful exit plan will be difficult, says former Fed governor and economics professor Randy Kroszner.
For the 2010 Morningstar Stocks Forum this week, we highlight several key questions to keep in mind as we observe management teams' presentations.
Given Macy's focus on its balance sheet and improving fundamentals, we think it will continue to generate cash and use it to predominantly favor financial health over growth.
Spirit AeroSystem's 2017 bond looks attractive, despite talk of defense budget cuts.
Three tricks and three treats for Halloween.
Increased spending on consumer services is a very positive sign for the economy, but imports continue to be a headwind to GDP, says Morningstar's Bob Johnson.
Morningstar securities analyst Dave Sekera offers tips for performing due diligence on a high-yield bond.
Some private-business owners wait until it is too late to find out how much their business is worth, says Morningstar's Alfonso Ventoso
Morningstar's Toan Tran expects more record quarters from the tech giant as new products and expanded distribution channels drive higher sales.
Linear Technology's convertible bonds look attractive according to Morningstar's Mike Hodel and Brian Colello.
After years of defensive moves, GE is beginning to invest in growth and return more cash to shareholders, says Morningstar's Daniel Holland.
Morningstar's Larry Witt thinks that despite attempts to diversify revenue streams, Google's revenue growth will slow considerably as comparisons to past quarters become more difficult.
As private equity begins flexing its muscles again, Morningstar's Pete Wahlstrom takes a closer look at three potential takeout candidates.
A tough competitive environment and exposure to market fluctuations make life insurance firm bonds less stable than many investors believe.
Josh Peters lays out his rules for building and maintaining a dividend portfolio that maximizes current income.
The smaller, nimbler investment portfolio of an individual investor would be a great gift for the Oracle.
The bonds of this boring, but consistently profitable company have a near-term upside catalyst, says Morningstar analyst Dan Rohr.
Patient yield seekers may get a better payoff by targeting names with strong dividend-growth prospects.
Bonds may have done well over the last decade but dividend paying stocks like J&J may be the best bet for the next ten years says Morningstar's Josh Peters.
As the economic recovery stalls, investors should look for firms with stable cash flows and competitive advantages.
Worries about the FDA's ruling on the relative safety of menthol cigarettes have left Lorillard's bonds looking attractively priced according to Morningstar's Dave Sekera.
Strong, stable cash flows should allow these firms to keep paying shareholders a hefty percentage of their earnings says Morningstar's Josh Peters.
After Mark Hurd's sudden departure, Hewlett-Packard shareholders need to examine these four issues to determine whether it's best to sell or hold.
Despite economic uncertainty, higher-end consumers appear to be opening their wallets wider.
Even if stocks tread water for another decade, dividends will still provide a real return to investors says Morningstar's Josh Peters.
Morningstar's Lauren DeSanto thinks that P&G's scale and investment in product development will allow it to serve consumers regardless of the economic backdrop.
Even if a potential Sanofi/Genzyme deal foretells a wave of consolidation, investors shouldn't worry about big pharma credit quality, says Morningstar's Julie Stralow.
Continued strength in corporate earnings shows there is still life in the recovery.
Morningstar's Joscelyn MacKay thinks the market is underestimating the strength of R.R. Donnelley.
Either the economic indicators are red herrings or corporate earnings are unsustainably high.
Morningstar's Erin Davis says European regulators should have used more stringent criteria to determine the health of banks.